Results of EORTC phase III trial 22931 comparing, postoperatively, radiotherapy (RT) to concurrent chemo-radiotherapy (RT-CT) with high dose cisplatin in locally advanced head and neck (H&N) carcinomas (SCC)
J. Bernier(Clinique de Genolier), Volker Budach(Humboldt-Universität zu Berlin), Jean-Francois Lefebvre, C. Domenge(Institut Gustave Roussy), M. Bolla(Centre Hospitalier Universitaire de Grenoble), F. Cognetti(Sapienza University of Rome), Mahmut Özşahin(University of Lausanne), P. Maingon, M. van Glabbeke(Institut Jules Bordet), P. Wibault(Institut Gustave Roussy), F. Rolland(Institut de Cancérologie de l'Ouest), Kathy Matuszewska
Cited by 15
Related Papers
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
|The Lancet|2005|1.1k
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k